Spain a 'prime candidate' to host post-Brexit EMA, Farmaindustria says

6 July 2016
spain-big-2

The Spanish government has confirmed its interest in Spain hosting the European Medicines Agency (EMA) if it moves from its current UK base following the vote for Brexit in last month’s referendum.

Farmaindustria, the trade group representing Spain’s pharmaceutical industry, has backed the move, saying Spain is a ‘prime candidate’ to host the agency.

Deputy Prime Minister of Spain, Soraya Sáenz de Santamaría, has called the EMA "of great interest to Spain,” saying the country’s competitiveness, important financial sector and its health system – “recognized as one of the world’s best” – strengthens its case.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical